+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Oral Vaccine Market Research Report by Application (Cholera, HIV, and Polio), by Type (Attenuated and Inactive), by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4995182
  • Report
  • July 2021
  • Region: Global
  • 181 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Oral Vaccine Market will Grow to USD 20.29 Billion by 2026, at a CAGR of 6.29%

FEATURED COMPANIES

  • Bull Bio - NCIPD Ltd.
  • GlaxoSmithKline plc
  • Immunitor, Inc
  • Merck & Co., Inc.
  • PaxVax Corporation
  • QUÍMICA SUIZA S.A.
The Global Oral Vaccine Market size was estimated at USD 14.07 Billion in 2020 and expected to reach USD 14.91 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 6.29% to reach USD 20.29 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Oral Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Application, the Oral Vaccine Market was studied across Cholera, HIV, Polio, Rabies, Respiratory Infection, and Tuberculosis.
  • Based on Type, the Oral Vaccine Market was studied across Attenuated and Inactive.
  • Based on End User, the Oral Vaccine Market was studied across Clinics and Hospitals.
  • Based on Region, the Oral Vaccine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Oral Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Oral Vaccine Market, including Bull Bio - NCIPD Ltd., Crucell (Johnson & Johnson), GlaxoSmithKline plc, Immunitor, Inc, Merck & Co., Inc., PaxVax Corporation, QUÍMICA SUIZA S.A., Serum Institute of India Pvt. Ltd., Shanghai BravoBio Co., Ltd., Shantha Biotechnics, Swiss Serum and Vaccine Institute Berne, VALNEVA Canada Inc., and Vaxart, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Oral Vaccine Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oral Vaccine Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oral Vaccine Market?
4. What is the competitive strategic window for opportunities in the Global Oral Vaccine Market?
5. What are the technology trends and regulatory frameworks in the Global Oral Vaccine Market?
6. What is the market share of the leading vendors in the Global Oral Vaccine Market?
7. What modes and strategic moves are considered suitable for entering the Global Oral Vaccine Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bull Bio - NCIPD Ltd.
  • GlaxoSmithKline plc
  • Immunitor, Inc
  • Merck & Co., Inc.
  • PaxVax Corporation
  • QUÍMICA SUIZA S.A.
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Application Outlook
3.4. Type Outlook
3.5. End User Outlook
3.6. Region Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Surge in the demand for needle-free vaccines by the pharmaceutical industry
5.1.1.2. Growing incidences of infectious diseases in the emerging countries
5.1.1.3. Increasing demand for cost-effective oral vaccines by consumers
5.1.2. Restraints
5.1.2.1. Side effects associated with the use of oral vaccines
5.1.3. Opportunities
5.1.3.1. Rising development in the oral vaccines products
5.1.3.2. Increasing government fundings for the research activities
5.1.4. Challenges
5.1.4.1. High cost of development and storage of the oral vaccine
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Oral Vaccine Market, by Application
6.1. Introduction
6.2. Cholera
6.3. HIV
6.4. Polio
6.5. Rabies
6.6. Respiratory Infection
6.7. Tuberculosis

7. Oral Vaccine Market, by Type
7.1. Introduction
7.2. Attenuated
7.3. Inactive

8. Oral Vaccine Market, by End User
8.1. Introduction
8.2. Clinics
8.3. Hospitals

9. Americas Oral Vaccine Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Oral Vaccine Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand

11. Europe, Middle East & Africa Oral Vaccine Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Bull Bio - NCIPD Ltd.
13.2. Crucell (Johnson & Johnson)
13.3. GlaxoSmithKline plc
13.4. Immunitor, Inc
13.5. Merck & Co., Inc.
13.6. PaxVax Corporation
13.7. QUÍMICA SUIZA S.A.
13.8. Serum Institute of India Pvt. Ltd.
13.9. Shanghai BravoBio Co., Ltd.
13.10. Shantha Biotechnics
13.11. Swiss Serum and Vaccine Institute Berne
13.12. VALNEVA Canada Inc.
13.13. Vaxart, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL ORAL VACCINE MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
FIGURE 3. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2020 (USD BILLION)
FIGURE 4. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2020 (USD BILLION)
FIGURE 5. GLOBAL ORAL VACCINE MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 6. GLOBAL ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 7. GLOBAL ORAL VACCINE MARKET: MARKET DYNAMICS
FIGURE 8. GLOBAL ORAL VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 9. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 10. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2026
FIGURE 12. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, 2018-2026 (USD BILLION)
FIGURE 13. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 14. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, 2018-2026 (USD BILLION)
FIGURE 15. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 16. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, 2018-2026 (USD BILLION)
FIGURE 17. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 18. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, 2018-2026 (USD BILLION)
FIGURE 19. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 20. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, 2018-2026 (USD BILLION)
FIGURE 21. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 22. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, 2018-2026 (USD BILLION)
FIGURE 23. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 24. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
FIGURE 25. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2026
FIGURE 27. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, 2018-2026 (USD BILLION)
FIGURE 28. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 29. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, 2018-2026 (USD BILLION)
FIGURE 30. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 31. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2020 VS 2026 (%)
FIGURE 32. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2026
FIGURE 34. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, 2018-2026 (USD BILLION)
FIGURE 35. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 36. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, 2018-2026 (USD BILLION)
FIGURE 37. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 38. AMERICAS ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. ARGENTINA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. BRAZIL ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. CANADA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. MEXICO ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. UNITED STATES ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. AUSTRALIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. CHINA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. INDIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. INDONESIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. JAPAN ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. MALAYSIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. PHILIPPINES ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. SINGAPORE ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. SOUTH KOREA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. THAILAND ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. FRANCE ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. GERMANY ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. ITALY ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. NETHERLANDS ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. QATAR ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. RUSSIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 62. SAUDI ARABIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 63. SOUTH AFRICA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 64. SPAIN ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 65. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 66. UNITED KINGDOM ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 67. GLOBAL ORAL VACCINE MARKET: FPNV POSITIONING MATRIX
FIGURE 68. GLOBAL ORAL VACCINE MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 69. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ORAL VACCINE MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL ORAL VACCINE MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL ORAL VACCINE MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL ORAL VACCINE MARKET SIZE, BY CHOLERA, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL ORAL VACCINE MARKET SIZE, BY HIV, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL ORAL VACCINE MARKET SIZE, BY POLIO, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL ORAL VACCINE MARKET SIZE, BY RABIES, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL ORAL VACCINE MARKET SIZE, BY RESPIRATORY INFECTION, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL ORAL VACCINE MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL ORAL VACCINE MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL ORAL VACCINE MARKET SIZE, BY ATTENUATED, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL ORAL VACCINE MARKET SIZE, BY INACTIVE, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL ORAL VACCINE MARKET SIZE, BY END USER, 2018-2026 (USD BILLION)
TABLE 15. GLOBAL ORAL VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2026 (USD BILLION)
TABLE 16. GLOBAL ORAL VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2026 (USD BILLION)
TABLE 17. AMERICAS ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 18. ARGENTINA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 19. BRAZIL ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. CANADA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. MEXICO ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. UNITED STATES ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. ASIA-PACIFIC ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. AUSTRALIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. CHINA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. INDIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. INDONESIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. JAPAN ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. MALAYSIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. PHILIPPINES ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. SINGAPORE ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. SOUTH KOREA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. THAILAND ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. FRANCE ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. GERMANY ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. ITALY ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. NETHERLANDS ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. QATAR ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. RUSSIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. SAUDI ARABIA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. SOUTH AFRICA ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. SPAIN ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. UNITED ARAB EMIRATES ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 45. UNITED KINGDOM ORAL VACCINE MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 46. GLOBAL ORAL VACCINE MARKET: SCORES
TABLE 47. GLOBAL ORAL VACCINE MARKET: BUSINESS STRATEGY
TABLE 48. GLOBAL ORAL VACCINE MARKET: PRODUCT SATISFACTION
TABLE 49. GLOBAL ORAL VACCINE MARKET: RANKING
TABLE 50. GLOBAL ORAL VACCINE MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 51. GLOBAL ORAL VACCINE MARKET: MERGER & ACQUISITION
TABLE 52. GLOBAL ORAL VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 53. GLOBAL ORAL VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 54. GLOBAL ORAL VACCINE MARKET: INVESTMENT & FUNDING
TABLE 55. GLOBAL ORAL VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 56. GLOBAL ORAL VACCINE MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Bull Bio - NCIPD Ltd.
  • Crucell (Johnson & Johnson)
  • GlaxoSmithKline plc
  • Immunitor, Inc
  • Merck & Co., Inc.
  • PaxVax Corporation
  • QUÍMICA SUIZA S.A.
  • Serum Institute of India Pvt. Ltd.
  • Shanghai BravoBio Co., Ltd.
  • Shantha Biotechnics
  • Swiss Serum and Vaccine Institute Berne
  • VALNEVA Canada Inc.
  • Vaxart, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll